|Dates & Locations:|| |
This subject has the following teaching availabilities in 2008:Semester 2, - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: 36 lectures and 12 tutorials |
Total Time Commitment: 120 hours
|Prerequisites:||One of Chemistry 610-141, 610-121 or 610-051 plus one of 610-142, 610-122 or 610-052. Concurrent enrolment in 610-245 is recommended.|
|Recommended Background Knowledge:||None|
|Non Allowed Subjects:||Credit cannot be gained for this subject and 610-240.|
|Core Participation Requirements:||It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. Students who feel their disability may impact upon their participation are encouraged to discuss this with the subject coordinator and the Disability Liaison Unit.|
CoordinatorAssociate Professor C G Young
|Subject Overview:|| |
Upon completion of 610-241, students should have an understanding of the central role of inorganic and bio-inorganic chemistry in biological systems, emerging industry processes and the action of metallo-drugs. This subject is developed via carefully chosen examples which include the role of nature's metal-scavanging ligands; the facilitation of life by the trace metals; organometallic chemistry; the design of catalysts in industry and nature (enzymes); and the design and action of metal drugs.
The subject covers the occurrence, uptake and transport of the essential trace elements; metal binding in complexes; iron nutrition in humans; transport of dioxygen by hemoglobin; the action of poisons; carbon monoxide and cyanide; organometallic chemistry; hydrogen, carbon monoxide and alkenes as ligands; the activation of ligands for reaction and the design of catalysts; structural and stereoscopic techniques; metal compounds as therapeutic agents including treatments for bipolar disorder (lithium) and cancer (cis-platin); toxic overload (chelation therapy); directed sythesis; the control of stereochemistry; structural inorganic chemistry; and the structural basis of advanced materials.
|Assessment:||A 50-minute multiple-choice examination held during the semester (10%); a 3-hour written examination in the examination period (90%).|
|Prescribed Texts:||Inorganic Chemistry (CE Housecroft and AG Sharpe), 2nd Ed. Prentice Hall, Harlow UK 2005|
|Breadth Options:||This subject is a level 2 or level 3 subject and is not available to new generation degree students as a breadth option in 2008. |
This subject or an equivalent will be available as breadth in the future.
Breadth subjects are currently being developed and these existing subject details can be used as guide to the type of options that might be available.
2009 subjects to be offered as breadth will be finalised before re-enrolment for 2009 starts in early October.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
Students enrolled in the BSc (pre-2008 BSc), BASc or a combined BSc course will receive science credit for the completion of this subject.
Download PDF version.